Skip to content

Cytokinetics CYTK Interest Paid

Interest Paid at other companies

Medtronic logo
MedtronicMDT
$201M+3.1%
Boston Scientific logo
Boston ScientificBSX
$79.75M+27.6%

Other financials

Income statement

See full
Revenue$19.4M+1,126%
Operating income-$183.6M-18.0%
Net income-$206.0M-27.7%
EPS (diluted)-$1.67-22.8%

Balance sheet

See full
Cash & equivalents$129.8M+76.2%
Total debt$418.2M+75.8%
Total equity-$826.6M-210%
Total assets$1.3B+0.7%

Cash flow

See full
Operating cash flow-$145.5M-10.5%
CapEx$5.9M+4.7%
Free cash flow-$151.4M-10.3%

Valuation

See full
Market cap$10.7B+70.6%
Enterprise value$10.98B+70.7%
P/S101.1×-225×

Profitability

See full
Operating margin-605.1%-268pp
Net margin-784%-337pp
FCF margin-518.8%-223pp

Returns & leverage

See full
Return on equity-337.6%
Debt / equity2.2×
Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytokinetics's interest paid?
Cytokinetics (CYTK) reported interest paid of $1.59M in Q1 2026.
How has Cytokinetics's interest paid changed year-over-year?
Cytokinetics's interest paid decreased by 83.6% year-over-year, from $9.65M to $1.59M.
What is the long-term trend for Cytokinetics's interest paid?
Over 4 years (2021 to 2025), Cytokinetics's interest paid has grown at a 25.7% compound annual growth rate (CAGR), from $9.18M to $22.91M.
What does interest paid mean?
The total cash paid to lenders for interest on debt.
How do you interpret interest paid?
An increase suggests higher debt levels or rising interest rates, which may impact future profitability and cash flow.
How does interest paid compare across companies?
Standard metric for all companies with debt; highly dependent on the company's credit profile and interest rate environment.